About
AllInBio develops a precision immunology approach to identify genetically predisposed patients at risk of rapidly progressing chronic inflammatory diseases, enabling their selection and early treatment to prevent severe disease progression.
Explore AllInBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.